InvestorsHub Logo
icon url

drugmanrx

02/15/22 1:26 PM

#102859 RE: BigE1960 #102858

Well, Since the filing was written in April 24 2021 and the statement says "over the period including 2020" that actual revenue was made in 2020.

Did you forget to highlight where they disclose actual revenue?



Sure seems to say actual revenue was made in 2020.

I even DID highlighted it in bold for you.

Also, on January 26, 2021, the Company and Pasaca entered into a Distribution Agreement (the “Distribution Agreement”). Pursuant to the terms of the Distribution Agreement, the Company appointed Pasaca to act as an independent distributor to resell and distribute the Company’s Quantum Dots and QMC HealthID products. Under the Distribution Agreement, Pasaca guaranteed that the Company would receive cumulative gross royalties and/or gross sales, licensing or other revenues under the Distribution Agreement of no less than $15,000,000, over the period including 2020 and continuing until twelve months after the Company has completed development of a functioning product integrating the QMC HealthID IP and Innova Medical Group’s products. Pasaca has the right to extend the revenue period by up to twenty-four months upon payment of advance royalties. At the date of this report, we have drawn $7,250,000 in advance draws, and these accrued interest at 8% until the date of conversion.